Volixibat
VLX-301
Phase 2 small_molecule active
Quick answer
Volixibat for Primary Sclerosing Cholangitis is a Phase 2 program (small_molecule) at Mirum Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mirum Pharmaceuticals
- Indication
- Primary Sclerosing Cholangitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active